| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Neupro 2 mg/24h | dispositif transdermique | dispositif transdermique () | N04BC09 | CI |
| 02 | Neupro 4 mg/24h | dispositif transdermique | dispositif transdermique () | N04BC09 | CI |
| 03 | Neupro 6 mg/24h | dispositif transdermique | dispositif transdermique () | N04BC09 | CI |
| 04 | Neupro 8 mg/24h | dispositif transdermique | dispositif transdermique () | N04BC09 | CI |
| 05 | Neupro 1 mg/24h | dispositif transdermique | dispositif transdermique () | N04BC09 | CI |
| 06 | Neupro 3 mg/24h | dispositif transdermique | dispositif transdermique () | N04BC09 | CI |
| 07 | Neupro 1 mg/24h | dispositif transdermique | | N04BC09 | CI |
| 08 | Neupro 2 mg/24h | dispositif transdermique | | N04BC09 | CI |
| 09 | Neupro 3 mg/24h | dispositif transdermique | | N04BC09 | CI |
| 10 | Neupro 4 mg/24h | dispositif transdermique | | N04BC09 | CI |
| 11 | Neupro 6 mg/24h | dispositif transdermique | | N04BC09 | CI |
| 12 | Neupro 8 mg/24h | dispositif transdermique | | N04BC09 | CI |
